Evidence map›Paper›PMID 36552581›Full record

ReviewAntioxidants (Basel, Switzerland)2022

Hexavalent-Chromium-Induced Oxidative Stress and the Protective Role of Antioxidants against Cellular Toxicity.

Veer Singh, Nidhi Singh, Manisha Verma, Rashmi Kamal, Ritesh Tiwari, Mahesh Sanjay Chivate, Sachchida Nand Rai, Ashish Kumar, Anupama Singh, Mohan P Singh and 2 more

Open access · goldAbstract readReview
In one paragraph

Review in Antioxidants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
15.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 177 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Rational design of a cascade CdS/CScientific reports · 2026
    Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Veer SinghSchool of Biochemical Engineering, Indian Institute of Technology, Banaras Hindu University, Varanasi 221005, India.
Nidhi SinghCentre of Bioinformatics, University of Allahabad, Prayagraj 211002, India.
Manisha VermaSchool of Biochemical Engineering, Indian Institute of Technology, Banaras Hindu University, Varanasi 221005, India.
Rashmi KamalSchool of Biochemical Engineering, Indian Institute of Technology, Banaras Hindu University, Varanasi 221005, India.
Ritesh TiwariDepartment of Biochemistry, Rajendra Memorial Research Institute of Medical Sciences, Patna 800007, India.ORCID 0000-0002-6593-6024
Mahesh Sanjay ChivateSchool of Biochemical Engineering, Indian Institute of Technology, Banaras Hindu University, Varanasi 221005, India.
Sachchida Nand RaiCentre of Biotechnology, University of Allahabad, Prayagraj 211002, India.ORCID 0000-0001-8418-9549
Ashish KumarDepartment of Biochemistry, Rajendra Memorial Research Institute of Medical Sciences, Patna 800007, India.
Anupama SinghCentre for Energy and Environment, Indian Institute of Technology, Patna 801106, India.
Mohan P SinghCentre of Biotechnology, University of Allahabad, Prayagraj 211002, India.ORCID 0000-0002-6236-856X
Emanuel VamanuFaculty of Biotechnology, University of Agricultural Sciences and Veterinary Medicine of Bucharest, 011464 Bucharest, Romania.ORCID 0000-0002-3376-2058
Vishal MishraSchool of Biochemical Engineering, Indian Institute of Technology, Banaras Hindu University, Varanasi 221005, India.
Banaras Hindu University · INUniversity of Allahabad · INRajendra Memorial Research Institute of Medical Sciences · INIndian Institute of Technology Patna · INUniversity of Agronomic Sciences and Veterinary Medicine of Bucharest · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hexavalent chromium is a highly soluble environmental contaminant. It is a widespread anthropogenic chromium species that is 100 times more toxic than trivalent chromium. Leather, chrome plating, coal mining and paint industries are the major sources of hexavalent chromium in water. Hexavalent chromium is widely recognised as a carcinogen and mutagen in humans and other animals. It is also responsible for multiorgan damage, such as kidney damage, liver failure, heart failure, skin disease and lung dysfunction. The fate of the toxicity of hexavalent chromium depends on its oxidation state. The reduction of Cr (VI) to Cr (III) is responsible for the generation of reactive oxygen species (ROS) and chromium intermediate species, such as Cr (V) and Cr (IV). Reactive oxygen species (ROS) are responsible for oxidative tissue damage and the disruption of cell organelles, such as mitochondria, DNA, RNA and protein molecules. Cr (VI)-induced oxidative stress can be neutralised by the antioxidant system in human and animal cells. In this review, the authors summarise the Cr (VI) source, toxicity and antioxidant defence mechanism against Cr (VI)-induced reactive oxygen species (ROS).

Indexed as

antioxidantsCr (VI) toxicityhexavalent chromiumreactive oxygen speciessource of Cr (VI)

Identifiers

PMID36552581
PMCPMC9774749
OpenAlexW4310478168

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.